Report overview
Serum HBV RNA can better reflect the activity of cccDNA in liver tissue. If the relapse risk of patients is predicted by detecting the level of HBV RNA in serum before drug withdrawal, it will help to identify those who have achieved virological response and are in the "Partially cured" patients who are able to maintain a virological response after drug discontinuation, thereby predicting the risk of virological rebound.
This report contains market size and forecasts of Hepatitis B RNA Detection Technology in Global, including the following market information:
Global Hepatitis B RNA Detection Technology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hepatitis B RNA Detection Technology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
RT PCR Technology Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis B RNA Detection Technology include Shanghai Rendu Biotechnology, Roche, Abbott, Shengxiang Biotechnology, Thermo Fisher, BGI, Daan Gene, Zhijiang Bio and Soworld Bio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis B RNA Detection Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B RNA Detection Technology Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis B RNA Detection Technology Market Segment Percentages, by Type, 2021 (%)
RT PCR Technology
RNA Isothermal Amplification Technology
Global Hepatitis B RNA Detection Technology Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis B RNA Detection Technology Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Hepatitis B RNA Detection Technology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hepatitis B RNA Detection Technology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B RNA Detection Technology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hepatitis B RNA Detection Technology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Shanghai Rendu Biotechnology
Roche
Abbott
Shengxiang Biotechnology
Thermo Fisher
BGI
Daan Gene
Zhijiang Bio
Soworld Bio
Halotier
Wuhan Zhongqi
